TMUNITY Trademark

Trademark Overview


On Tuesday, May 26, 2020, a trademark application was filed for TMUNITY with the United States Patent and Trademark Office. The USPTO has given the TMUNITY trademark a serial number of 88932728. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by Tmunity Therapeutics, Inc. The TMUNITY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the diagnosis of cancer, organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; diagnostic reagents for the diagnosis of cancer; diagnostic reagents and therapeutic reagents for the diagnosis and treatment of organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; gene therapy products, namely, engineered cell platforms for immunotherapy purposes

Scientific research; pharmaceutical research; medical research; technological consultation services in the field of manufacturing pharmaceuticals; product development; laboratory research services in the field of immunology and cellular engineering; medical laboratory services
tmunity

General Information


Serial Number88932728
Word MarkTMUNITY
Filing DateTuesday, May 26, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the diagnosis of cancer, organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; diagnostic reagents for the diagnosis of cancer; diagnostic reagents and therapeutic reagents for the diagnosis and treatment of organ transplant rejection, autoimmune and infectious diseases, and autoimmune and infectious conditions; gene therapy products, namely, engineered cell platforms for immunotherapy purposes
Goods and ServicesScientific research; pharmaceutical research; medical research; technological consultation services in the field of manufacturing pharmaceuticals; product development; laboratory research services in the field of immunology and cellular engineering; medical laboratory services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 11, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTmunity Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Party NameTmunity Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events


Event DateEvent Description
Friday, May 29, 2020NEW APPLICATION ENTERED
Thursday, June 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 26, 2020ASSIGNED TO EXAMINER
Friday, August 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 10, 2021SOU TEAS EXTENSION RECEIVED
Monday, May 10, 2021SOU EXTENSION 1 FILED
Monday, May 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, May 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 17, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 17, 2021SOU EXTENSION 2 FILED
Wednesday, November 17, 2021SOU EXTENSION 2 GRANTED
Friday, November 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2022SOU TEAS EXTENSION RECEIVED
Thursday, May 19, 2022SOU EXTENSION 3 FILED
Thursday, May 19, 2022SOU EXTENSION 3 GRANTED
Saturday, May 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 21, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 21, 2022SOU EXTENSION 4 FILED
Friday, December 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 2, 2022SOU EXTENSION 4 GRANTED
Saturday, December 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023SOU EXTENSION 5 FILED
Saturday, June 3, 2023SOU EXTENSION 5 GRANTED
Tuesday, June 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED